Home > PE Ratio > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
PE (Price/Earnings) Ratio

The Current P/E Ratio of SYNCOM FORMULATIONS (INDIA) is 39.83.

Share Price ₹11.2Mar 28,2024
Market Cap ₹1,050.9 Cr
Earnings-TTM₹26.4 CrTTM-Consolidated Results
Price/Earnings39.83xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of SYNCOM FORMULATIONS (INDIA)

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SYNCOM FORMULATIONS (INDIA) is calculated as :

Current Market Cap [ ₹1,050.9 Cr] as on Mar 28,2024

(/) Earnings [ ₹26.4 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 39.83x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SYNCOM FORMULATIONS (INDIA) , the investors are currently willing to pay 39.83 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SYNCOM FORMULATIONS (INDIA) !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SYNCOM FORMULATIONS (INDIA) over the last five years.

Historical PE (Price/Earnings) ratio chart of SYNCOM FORMULATIONS (INDIA)


PE Ratio Performance Analysis for SYNCOM FORMULATIONS (INDIA)

- SYNCOM FORMULATIONS (INDIA) 's latest p/e ratio is 39.83x.

- SYNCOM FORMULATIONS (INDIA) 's p/e ratio for fiscal years ending Mar2023 to Mar2015 averaged 27.93x.

- SYNCOM FORMULATIONS (INDIA) 's operated at median p/e ratio of 27.63x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SYNCOM FORMULATIONS (INDIA) 's p/e ratio peaked in Mar2022 at 46.32x.

- SYNCOM FORMULATIONS (INDIA) 's p/e ratio hit its five-year low in Mar2017 of 14.6x.


How does SYNCOM FORMULATIONS (INDIA) 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SYNCOM FORMULATIONS (INDIA) 26.3839.831,050.9
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6343.21388,812.0
CIPLA LTD3,744.0332.23120,673.0
DR REDDYS LABORATORIES LTD5,209.4019.71102,679.0
ZYDUS LIFESCIENCES LTD2,954.2034.24101,152.0
DIVIS LABORATORIES LTD1,382.9765.9791,234.9
MANKIND PHARMA LTD1,743.3052.7992,029.2
TORRENT PHARMACEUTICALS LTD1,494.0058.9388,034.7
LUPIN LTD1,809.7440.7473,722.0
AUROBINDO PHARMA LTD2,777.8922.9863,835.1
ABBOTT INDIA LTD1,145.5849.9857,258.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SYNCOM FORMULATIONS (INDIA) 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.71x
Max industry PE 65.97x
Median industry PE 40.74x
Average industry PE 41.87x



You may also like the below Video Courses